Skip to main content
TipRanks
Go Ultimate75% OFF

VentriPoint Diagnostics (5V7) Stock Price & Analysis

0 Followers

5V7 Stock Chart & Stats

€0.03€0.00(0.00%)
At close: 5:30 PM GMT+1
€0.08€0.085€0.09Jun 23Jul 17Aug 6
Day’s Range
EUR 0.03 - EUR 0.03
52-Week Range
EUR 0.03 - EUR 0.09
Previous Close
EUR 0.03
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 7.97M
Enterprise Value
EUR 22.72M
Total Cash (Recent Filing)
EUR 333.63K
Total Debt (Recent Filing)
EUR 2.62M
Price to Earnings (P/E)
―
Beta
-0.52
Next Earnings
Dec 02, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

TTM revenue growth of 15.3% indicates that the company is expanding commercial activity and gaining adoption for its cardiac imaging software. Continued top-line growth can improve operating leverage over time, broaden the customer base, and provide a stronger foundation for future profitability.

High Gross Margin

A gross margin near 89.6% reflects attractive underlying economics for the company’s software and diagnostic analytics offering. If revenue continues to scale, the limited direct cost burden could allow a larger share of incremental sales to support development, commercialization, and eventual operating profitability.

Narrowing Losses

The meaningful reduction in losses versus 2023–2024 suggests that operating performance is moving in a better direction, even though the company remains unprofitable. Sustaining this improvement would reduce the distance to break-even and could make future revenue growth more financially productive.

Bears Say

Persistent Unprofitability

Negative net margin, EBIT, and EBITDA show that the company’s current revenue base does not yet cover its operating cost structure. Continued losses can constrain investment capacity and make the benefits of strong revenue growth dependent on further expense control or additional financing.

Negative Cash Flow

Operating and free cash flow of approximately negative $1.92 million indicate that the business is still consuming cash to fund operations rather than generating internal liquidity. Although burn has improved from prior years, ongoing cash needs may limit strategic flexibility and require continued external support.

Deteriorated Capital Structure

Negative equity and debt that exceeds the stated asset base indicate a materially stressed capital structure. The shift from positive equity in 2022–2023 to negative equity in 2024–TTM reduces financial flexibility, increases dependence on external financing, and heightens the consequences of continued losses.

VentriPoint Diagnostics News

5V7 FAQ

What was VentriPoint Diagnostics’s price range in the past 12 months?
VentriPoint Diagnostics lowest stock price was €0.03 and its highest was €0.09 in the past 12 months.
What is VentriPoint Diagnostics’s market cap?
VentriPoint Diagnostics’s market cap is €7.97M.
When is VentriPoint Diagnostics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were VentriPoint Diagnostics’s earnings last quarter?
VentriPoint Diagnostics released its earnings results on Sep 01, 2026. The company reported -€0.004 earnings per share for the quarter.
Is VentriPoint Diagnostics overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does VentriPoint Diagnostics pay dividends?
VentriPoint Diagnostics does not currently pay dividends.
What is VentriPoint Diagnostics’s EPS estimate?
VentriPoint Diagnostics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VentriPoint Diagnostics have?
VentriPoint Diagnostics has 192,877,940 shares outstanding.
What happened to VentriPoint Diagnostics’s price movement after its last earnings report?
VentriPoint Diagnostics reported an EPS of -€0.004 in its last earnings report. Following the earnings report the stock price went down -5.769%.
Which hedge fund is a major shareholder of VentriPoint Diagnostics?
Currently, no hedge funds are holding shares in DE:5V7
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology